chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness
Clinical narrative: intense pain between eyes; difficulty standing and walking due to feeling disoriented; throat felt tight; Seeing trails of moving objects; difficulty transferring thoughts into; This is a spontaneous report from a contactable consumer. A 44-year-old non pregnant female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot No: EN6203), Intramuscularly on 02Mar2021 at 14:00 pm into Left arm as a single dose for COVID-19 immunization. Medical history included heart rate irregular from an unknown date and unknown if ongoing, gastroesophageal reflux disease from an unknown date and unknown if ongoing. Concomitant medication(s) included flecainide taken for an unspecified indication, start and stop date were not reported; pantoprazole taken for an unspecified indication, start and stop date were not reported; spironolactone taken for an unspecified indication, start and stop date were not reported and vitamin. Patient did not receive any other vaccine in four weeks. On 02Mar2021 at 15:00 pm, the patient experienced Seeing trails of moving objects, difficulty transferring thoughts into words, difficulty standing and walking due to feeling disoriented, throat felt tight, intense pain between eyes. Prior the vaccination, patient was not diagnosed with COVID. Post vaccination, Patient was not tested with COVID. Patient had no allergies. No treatment drug was given for the events. The outcome of the events was recovered. No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Disorientation, Dysgraphia, Eye pain, Oscillopsia, Throat tightness
Clinical narrative: intense pain between eyes; difficulty standing and walking due to feeling disoriented; throat felt tight; Seeing trails of moving objects; difficulty transferring thoughts into; This is a spontaneous report from a contactable consumer. A 44-year-old non pregnant female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot No: EN6203), Intramuscularly on 02Mar2021 at 14:00 pm into Left arm as a single dose for COVID-19 immunization. Medical history included heart rate irregular from an unknown date and unknown if ongoing, gastroesophageal reflux disease from an unknown date and unknown if ongoing. Concomitant medication(s) included flecainide taken for an unspecified indication, start and stop date were not reported; pantoprazole taken for an unspecified indication, start and stop date were not reported; spironolactone taken for an unspecified indication, start and stop date were not reported and vitamin. Patient did not receive any other vaccine in four weeks. On 02Mar2021 at 15:00 pm, the patient experienced Seeing trails of moving objects, difficulty transferring thoughts into words, difficulty standing and walking due to feeling disoriented, throat felt tight, intense pain between eyes. Prior the vaccination, patient was not diagnosed with COVID. Post vaccination, Patient was not tested with COVID. Patient had no allergies. No treatment drug was given for the events. The outcome of the events was recovered. No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Loud, high pitched ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via unspecified route of administration on 04Mar2021 at 16:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid, obesity, Rathke's cleft cyst and atrial fibrillation. It was reported that the patient was allergic to latex, cephalosporins, beta blockers and penicillin. Concomitant medications included clonidine (MANUFACTURER UNKNOWN), SYNTHROID, levocetirizine (MANUFACTURER UNKNOWN) and CYTOMEL. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Mar2021 at 20:00 (within a few hours of coming home from the shot), the patient experienced a loud, high pitched ringing in her ears. She thought it would go away. Almost 3 weeks later it had not. It was awful. Occasionally it would dip down to a lower pitch, but then it returned. It was absolutely maddening, and enough to make her skittish of the second shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event loud, high pitched ringing in ears was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chest discomfort, Chest pain, Dyspnoea, Injection site pain
Clinical narrative: a fiery pain began at injection site and went up to shoulder and down left side of chest; Some chest tightening; shortness of breath; pain was so bad; This is a spontaneous report from a contactable consumer (Patient). A 39-years-old female non-pregnant patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6204), via an unspecified route of administration, administered in left arm on 09Mar2021 10:15 (at the age of 39-years-old) as single dose for COVID-19 immunization. Medical history included obesity, hypertension, depression, anxiety, polycystic ovaries, hypothyroidism, blindness, covid-19. Concomitant medications included Wellbutrin SR, Hydrochlorothiazide, Zoloft, more.The patient had allergies with topamax and temporarily lost vision in. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Mar2021 12:45, approximately 2.5 hours after injection, a fiery pain began at injection site and went up to shoulder and down left side of chest. Some chest tightening and shortness of breath occurred. Was reaching for phone to call ambulance as the pain was so bad, when it started to fade after about a minute. Chest tightening and shortness of breath resolved a couple minutes later. I have never had a reaction like this to any vaccine or medication. I have messaged my doctor to ask if I should cancel the second dose. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment. Outcome of the event was recovered on 09Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: a fiery pain began at injection site and went up to shoulder and down left side of chest; Some chest tightening; shortness of breath; pain was so bad; This is a spontaneous report from a contactable consumer (Patient). A 39-years-old female non-pregnant patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6204), via an unspecified route of administration, administered in left arm on 09Mar2021 10:15 (at the age of 39-years-old) as single dose for COVID-19 immunization. Medical history included obesity, hypertension, depression, anxiety, polycystic ovaries, hypothyroidism, blindness, covid-19. Concomitant medications included Wellbutrin SR, Hydrochlorothiazide, Zoloft, more.The patient had allergies with topamax and temporarily lost vision in. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Mar2021 12:45, approximately 2.5 hours after injection, a fiery pain began at injection site and went up to shoulder and down left side of chest. Some chest tightening and shortness of breath occurred. Was reaching for phone to call ambulance as the pain was so bad, when it started to fade after about a minute. Chest tightening and shortness of breath resolved a couple minutes later. I have never had a reaction like this to any vaccine or medication. I have messaged my doctor to ask if I should cancel the second dose. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment. Outcome of the event was recovered on 09Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dyspnoea, Pain, Vaccination site pain
Clinical narrative: a fiery pain began at injection site and went up to shoulder and down left side of chest; Some chest tightening; shortness of breath; pain was so bad; This is a spontaneous report from a contactable consumer (Patient). A 39-years-old female non-pregnant patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6204), via an unspecified route of administration, administered in left arm on 09Mar2021 10:15 (at the age of 39-years-old) as single dose for COVID-19 immunization. Medical history included obesity, hypertension, depression, anxiety, polycystic ovaries, hypothyroidism, blindness, covid-19. Concomitant medications included Wellbutrin SR, Hydrochlorothiazide, Zoloft, more.The patient had allergies with topamax and temporarily lost vision in. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Mar2021 12:45, approximately 2.5 hours after injection, a fiery pain began at injection site and went up to shoulder and down left side of chest. Some chest tightening and shortness of breath occurred. Was reaching for phone to call ambulance as the pain was so bad, when it started to fade after about a minute. Chest tightening and shortness of breath resolved a couple minutes later. I have never had a reaction like this to any vaccine or medication. I have messaged my doctor to ask if I should cancel the second dose. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment. Outcome of the event was recovered on 09Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue, Throat tightness
Clinical narrative: Throat felt like it was getting tight; left side tongue and cheek numbness; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6201) via unknown route of administration in her left arm on 11Mar2021 at 17:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patients medical history included thyroid cancer. Concomitant medication included CYTOMEL, citalopram (MANUFACTURER UNKNOWN), SYNTHROID, Vitamin D (MANUFACTURER UNKNOWN) for unknown indication. Patient was allergic to penicillin and erythromycin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested positive for COVID-19 since having the vaccine. After vaccination on 11Mar2021, patient experienced throat tightness and numbness in left side tongue and cheek when she took Benadryl. Then patient went to urgent care center where benadryl kicked in and the patient started to feel better by the time doctor came in. The adverse event resulted in a visit to the Emergency room/department or urgent care. The clinical outcome of throat tightness and numbness in left side of tongue and cheek was reported as resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Throat tightness
Clinical narrative: Throat felt like it was getting tight; left side tongue and cheek numbness; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6201) via unknown route of administration in her left arm on 11Mar2021 at 17:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patients medical history included thyroid cancer. Concomitant medication included CYTOMEL, citalopram (MANUFACTURER UNKNOWN), SYNTHROID, Vitamin D (MANUFACTURER UNKNOWN) for unknown indication. Patient was allergic to penicillin and erythromycin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested positive for COVID-19 since having the vaccine. After vaccination on 11Mar2021, patient experienced throat tightness and numbness in left side tongue and cheek when she took Benadryl. Then patient went to urgent care center where benadryl kicked in and the patient started to feel better by the time doctor came in. The adverse event resulted in a visit to the Emergency room/department or urgent care. The clinical outcome of throat tightness and numbness in left side of tongue and cheek was reported as resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, COVID-19, Dyspnoea, Eye pain
Clinical narrative: some shortness of breath on exertion; Headaches; joint pain; body aches; eye soreness; red eyes; brain fog; severe fatigue; pain around back and ribs; pain around back and ribs; pain at back of neck; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received BNT162B2(PFIZER BIONTECH, COVID-19 Vaccine, Solution for injection, Lot number: EN6199, Expiration date: Not reported) via an unspecified route of administration, administered in arm left on 05Mar2021 14:30 as DOSE 1, SINGLE for COVID-19 IMMUNISATION. Medical history included Post-acute covid 19 syndrome, chronic fatigue syndrome, COVID-19, migraine and sick from Mar2020 to an unknown date. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), nortriptyline and ergocalciferol (VITAMIN D [ERGOCALCIFEROL]). Patient did not receive any vaccine in four weeks. On 11Mar2021, at 8.00 patient experienced headaches, body aches, joint pain, eye soreness, red eyes, brain fog, severe fatigue, pain around back and ribs, pain at back of neck, some shortness of breath on exertion. She reported to have post acute covid 19 syndrome since getting sick in Mar2020 and this has been a severe relapse, after several months of improvement. She received unspecified treatment for the events. The outcome of all the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Loss of personal independence in daily activities, Malaise, Musculoskeletal chest pain, Ocular hyperaemia
Clinical narrative: some shortness of breath on exertion; Headaches; joint pain; body aches; eye soreness; red eyes; brain fog; severe fatigue; pain around back and ribs; pain around back and ribs; pain at back of neck; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received BNT162B2(PFIZER BIONTECH, COVID-19 Vaccine, Solution for injection, Lot number: EN6199, Expiration date: Not reported) via an unspecified route of administration, administered in arm left on 05Mar2021 14:30 as DOSE 1, SINGLE for COVID-19 IMMUNISATION. Medical history included Post-acute covid 19 syndrome, chronic fatigue syndrome, COVID-19, migraine and sick from Mar2020 to an unknown date. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), nortriptyline and ergocalciferol (VITAMIN D [ERGOCALCIFEROL]). Patient did not receive any vaccine in four weeks. On 11Mar2021, at 8.00 patient experienced headaches, body aches, joint pain, eye soreness, red eyes, brain fog, severe fatigue, pain around back and ribs, pain at back of neck, some shortness of breath on exertion. She reported to have post acute covid 19 syndrome since getting sick in Mar2020 and this has been a severe relapse, after several months of improvement. She received unspecified treatment for the events. The outcome of all the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain
Clinical narrative: some shortness of breath on exertion; Headaches; joint pain; body aches; eye soreness; red eyes; brain fog; severe fatigue; pain around back and ribs; pain around back and ribs; pain at back of neck; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received BNT162B2(PFIZER BIONTECH, COVID-19 Vaccine, Solution for injection, Lot number: EN6199, Expiration date: Not reported) via an unspecified route of administration, administered in arm left on 05Mar2021 14:30 as DOSE 1, SINGLE for COVID-19 IMMUNISATION. Medical history included Post-acute covid 19 syndrome, chronic fatigue syndrome, COVID-19, migraine and sick from Mar2020 to an unknown date. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), nortriptyline and ergocalciferol (VITAMIN D [ERGOCALCIFEROL]). Patient did not receive any vaccine in four weeks. On 11Mar2021, at 8.00 patient experienced headaches, body aches, joint pain, eye soreness, red eyes, brain fog, severe fatigue, pain around back and ribs, pain at back of neck, some shortness of breath on exertion. She reported to have post acute covid 19 syndrome since getting sick in Mar2020 and this has been a severe relapse, after several months of improvement. She received unspecified treatment for the events. The outcome of all the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Dyspnoea, Eye pain, Fatigue
Clinical narrative: some shortness of breath on exertion; Headaches; joint pain; body aches; eye soreness; red eyes; brain fog; severe fatigue; pain around back and ribs; pain around back and ribs; pain at back of neck; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received BNT162B2(PFIZER BIONTECH, COVID-19 Vaccine, Solution for injection, Lot number: EN6199, Expiration date: Not reported) via an unspecified route of administration, administered in arm left on 05Mar2021 14:30 as DOSE 1, SINGLE for COVID-19 IMMUNISATION. Medical history included Post-acute covid 19 syndrome, chronic fatigue syndrome, COVID-19, migraine and sick from Mar2020 to an unknown date. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), nortriptyline and ergocalciferol (VITAMIN D [ERGOCALCIFEROL]). Patient did not receive any vaccine in four weeks. On 11Mar2021, at 8.00 patient experienced headaches, body aches, joint pain, eye soreness, red eyes, brain fog, severe fatigue, pain around back and ribs, pain at back of neck, some shortness of breath on exertion. She reported to have post acute covid 19 syndrome since getting sick in Mar2020 and this has been a severe relapse, after several months of improvement. She received unspecified treatment for the events. The outcome of all the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Headache, Musculoskeletal chest pain, Neck pain, Ocular hyperaemia
Clinical narrative: some shortness of breath on exertion; Headaches; joint pain; body aches; eye soreness; red eyes; brain fog; severe fatigue; pain around back and ribs; pain around back and ribs; pain at back of neck; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received BNT162B2(PFIZER BIONTECH, COVID-19 Vaccine, Solution for injection, Lot number: EN6199, Expiration date: Not reported) via an unspecified route of administration, administered in arm left on 05Mar2021 14:30 as DOSE 1, SINGLE for COVID-19 IMMUNISATION. Medical history included Post-acute covid 19 syndrome, chronic fatigue syndrome, COVID-19, migraine and sick from Mar2020 to an unknown date. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), nortriptyline and ergocalciferol (VITAMIN D [ERGOCALCIFEROL]). Patient did not receive any vaccine in four weeks. On 11Mar2021, at 8.00 patient experienced headaches, body aches, joint pain, eye soreness, red eyes, brain fog, severe fatigue, pain around back and ribs, pain at back of neck, some shortness of breath on exertion. She reported to have post acute covid 19 syndrome since getting sick in Mar2020 and this has been a severe relapse, after several months of improvement. She received unspecified treatment for the events. The outcome of all the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acne, Burning sensation, Paraesthesia
Clinical narrative: acne breakout on my scalp and on my temples; potential shingles flare up; burning/tingling sensation on the left side of my face; burning/tingling sensation on the left side of my face; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration in the right arm on 01Mar2021 at 11:30 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. Medical history included allergies to phenergan drug and strawberries. Concomitant medications taken within two weeks included PROPECIA, losartan pot (MANUFACTURER UNKNOWN), probiotic (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN) and vitamin C (MANUFACTURER UNKNOWN) all for unknown indications from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 02Mar2021, a day after vaccination, the patient had a bad acne breakout on his scalp and temples. On an unknown date in Mar2021 (two-week mark), the patient experienced burning/tingling sensation on the left side of his face (near to left eye) which the patient interpreted as a potential shingles flare up. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a results of event acne and shingles flare up included treatment with doxycycline (on dermatologist visit) on 03Mar2021 and Valtrex for 7 days, respectively. The clinical outcome of events acne, potential shingles, burning sensation and tingling was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acne, Burning sensation, Herpes zoster, Paraesthesia
Clinical narrative: acne breakout on my scalp and on my temples; potential shingles flare up; burning/tingling sensation on the left side of my face; burning/tingling sensation on the left side of my face; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration in the right arm on 01Mar2021 at 11:30 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. Medical history included allergies to phenergan drug and strawberries. Concomitant medications taken within two weeks included PROPECIA, losartan pot (MANUFACTURER UNKNOWN), probiotic (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN) and vitamin C (MANUFACTURER UNKNOWN) all for unknown indications from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 02Mar2021, a day after vaccination, the patient had a bad acne breakout on his scalp and temples. On an unknown date in Mar2021 (two-week mark), the patient experienced burning/tingling sensation on the left side of his face (near to left eye) which the patient interpreted as a potential shingles flare up. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a results of event acne and shingles flare up included treatment with doxycycline (on dermatologist visit) on 03Mar2021 and Valtrex for 7 days, respectively. The clinical outcome of events acne, potential shingles, burning sensation and tingling was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mouth ulceration
Clinical narrative: ulcers in mouth causing swelling and pain; This is a spontaneous report received from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9266) via an unspecified route of administration in the right arm on 26Feb2021 at 13:30 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and thyroid. The patient was allergic to aspirin and tetracycline. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included thyroid and statin medications (unspecified). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in right arm on 04Feb2021 at 00:00 (at the age of 70-years-old) as a single dose, for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccination. On 12Mar2021 at 04:00, the patient experienced ulcers in mouth which caused swelling and pain. The patient did not receive any treatment for the event ulcers in mouth. The adverse event resulted in doctor or other healthcare professional office or clinic visit. The clinical outcome of the event ulcers in mouth was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Headache, Hyperhidrosis, Injection site induration, Injection site pain
Clinical narrative: waves of nausea; diarrhea; pain and stiffness that slowly spread down left arm; sweating; Didn't feel well; pain and stiffness that slowly spread down left arm; headache; low-grade fever during night; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 at 09:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal asthma, overweight, bronchitis, uterine fibroids and endometriosis. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), ADVIL, TUMS and RICOLA for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 10: 45, the patient did not feel well, pain and stiffness that slowly spread down left arm (below injection site), headache, low-grade fever during night then sweating. On the following day on 13Mar2021, the patient experienced waves of nausea and diarrhoea. The patient felt okay approximately (32 hrs after injection). The patient did not receive any treatment for the reported events. The events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of did not feel well, pain and stiffness that slowly spread down left arm, headache, low-grade fever, sweating, waves of nausea and diarrhoea was resolved in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Nausea, Pyrexia
Clinical narrative: waves of nausea; diarrhea; pain and stiffness that slowly spread down left arm; sweating; Didn't feel well; pain and stiffness that slowly spread down left arm; headache; low-grade fever during night; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 at 09:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal asthma, overweight, bronchitis, uterine fibroids and endometriosis. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), ADVIL, TUMS and RICOLA for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 10: 45, the patient did not feel well, pain and stiffness that slowly spread down left arm (below injection site), headache, low-grade fever during night then sweating. On the following day on 13Mar2021, the patient experienced waves of nausea and diarrhoea. The patient felt okay approximately (32 hrs after injection). The patient did not receive any treatment for the reported events. The events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of did not feel well, pain and stiffness that slowly spread down left arm, headache, low-grade fever, sweating, waves of nausea and diarrhoea was resolved in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Headache, Hyperhidrosis, Malaise, Musculoskeletal stiffness
Clinical narrative: waves of nausea; diarrhea; pain and stiffness that slowly spread down left arm; sweating; Didn't feel well; pain and stiffness that slowly spread down left arm; headache; low-grade fever during night; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 at 09:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal asthma, overweight, bronchitis, uterine fibroids and endometriosis. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), ADVIL, TUMS and RICOLA for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 10: 45, the patient did not feel well, pain and stiffness that slowly spread down left arm (below injection site), headache, low-grade fever during night then sweating. On the following day on 13Mar2021, the patient experienced waves of nausea and diarrhoea. The patient felt okay approximately (32 hrs after injection). The patient did not receive any treatment for the reported events. The events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of did not feel well, pain and stiffness that slowly spread down left arm, headache, low-grade fever, sweating, waves of nausea and diarrhoea was resolved in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia
Clinical narrative: waves of nausea; diarrhea; pain and stiffness that slowly spread down left arm; sweating; Didn't feel well; pain and stiffness that slowly spread down left arm; headache; low-grade fever during night; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 at 09:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal asthma, overweight, bronchitis, uterine fibroids and endometriosis. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), ADVIL, TUMS and RICOLA for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 10: 45, the patient did not feel well, pain and stiffness that slowly spread down left arm (below injection site), headache, low-grade fever during night then sweating. On the following day on 13Mar2021, the patient experienced waves of nausea and diarrhoea. The patient felt okay approximately (32 hrs after injection). The patient did not receive any treatment for the reported events. The events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of did not feel well, pain and stiffness that slowly spread down left arm, headache, low-grade fever, sweating, waves of nausea and diarrhoea was resolved in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling in my left hand and fingers; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route administration in left arm on 17Mar2021 at 1600 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. The medical history of the patient included known allergic to sulfur and blood pressure high. The patient has received unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 17Mar2021, at 1630, the patient had tingling in her left hand and fingers. She felt tingling in her left hand shortly after the injection, but she did not think that was unusual. Then she had completed full two days since the injection and had the same tingling. The patient did not receive any treatment for the events. The clinical outcome of tingling was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Dizziness; nausea; This is a spontaneous report from a contactable consumer, patient. A 71-year-old male patient received second dose of BNT162b2(PFIZER-BIONTECH COVID19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on the left arm as a single dose on 15Mar2021 at 14:00 (at the age of 71-year-old) for COVID-19 vaccination. The patients medical history included high blood pressure. The patient did not have any allergies to medication, food or other products. Concomitant medication taken within two weeks included lisinopril (MANUFACTURER UNKNOWN) and finasteride (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2(PFIZER-BIONTECH COVID19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on the arm as a single dose on 22feb2021 (at the age of 71-year-old) for COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 15Mar2021 at 20:00 the patient developed dizziness and nausea that persisted for three days. The patient did not receive any treatment for the adverse events. The outcome of the events dizziness and nausea was recovering at the time of report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue
Clinical narrative: Joint pain; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE BIONTECH, Lot Number: EN6208) via an unspecified route of administration in the left arm on 16Mar2021 at 16:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included unspecified allergies on an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not tested for COVID-19. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), ezetimibe (MANUFACTURER UNKNOWN), loratadine (MANUFACTURER UNKNOWN) and memantine HCL (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and these medications were used within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 17Mar2021, patient experienced joint pain and fatigue. Therapeutic measures were taken for the events joint pain and fatigue and included treatment with acetaminophen with caffeine and lidocaine patch. The clinical outcome of the events joint pain and fatigue were not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Dyspepsia, Liver disorder
Clinical narrative: Burning stomach pain starting in upper and traveling to lower stomach; Severe pain coming and going around liver area; Burning stomach pain starting in upper and traveling to lower stomach; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: unknown) via an unspecified route of administration in the left arm on 18Mar2021 at 11:00 (at the age of 23-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma, birth control and fruit allergy with kiwi, spinach, bananas, pineapple on an unknown date. Concomitant medications included albuterol (MANUFACTURER UNKNOWN) for unknown indication, wixela (MANUFACTURER UNKNOWN) for asthma and gianvi (MANUFACTURER UNKNOWN) for birth control on an unknown date and these medications were used within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 10:00, patient experienced severe pain coming and going around liver area and burning stomach pain starting in upper and traveling to lower stomach. The patient did not receive any treatment for the events. The outcome of the severe pain coming and going around liver area and burning stomach pain starting in upper and traveling to lower stomach was recovering.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Dyspepsia, Hepatic pain
Clinical narrative: Burning stomach pain starting in upper and traveling to lower stomach; Severe pain coming and going around liver area; Burning stomach pain starting in upper and traveling to lower stomach; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: unknown) via an unspecified route of administration in the left arm on 18Mar2021 at 11:00 (at the age of 23-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma, birth control and fruit allergy with kiwi, spinach, bananas, pineapple on an unknown date. Concomitant medications included albuterol (MANUFACTURER UNKNOWN) for unknown indication, wixela (MANUFACTURER UNKNOWN) for asthma and gianvi (MANUFACTURER UNKNOWN) for birth control on an unknown date and these medications were used within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 10:00, patient experienced severe pain coming and going around liver area and burning stomach pain starting in upper and traveling to lower stomach. The patient did not receive any treatment for the events. The outcome of the severe pain coming and going around liver area and burning stomach pain starting in upper and traveling to lower stomach was recovering.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ear discomfort, Tinnitus
Clinical narrative: Ringing in ears with pressure; Hard to go to sleep; This is a spontaneous report received from a contactable consumer, the patient. A 70-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 08Mar2021 at 14:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have allergies to medications, food or other products. Concomitant medication included simvastatin (MANUFACTURER UNKNOWN) for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 10702), via an unspecified route of administration in the right arm an 08Feb2021 at 13:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Mar2021 at 16:00, 2 hours after vaccination, the patient got a ringing in his ears with pressure. It was reported that patient ears rang all the time and had not let up yet at the time of reporting. It made it hard to go to sleep and the ringing was 24 hours a day. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the ringing in ears with pressure and hard to go to sleep was not recovered.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Tinnitus
Clinical narrative: Ringing in ears with pressure; Hard to go to sleep; This is a spontaneous report received from a contactable consumer, the patient. A 70-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 08Mar2021 at 14:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have allergies to medications, food or other products. Concomitant medication included simvastatin (MANUFACTURER UNKNOWN) for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 10702), via an unspecified route of administration in the right arm an 08Feb2021 at 13:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Mar2021 at 16:00, 2 hours after vaccination, the patient got a ringing in his ears with pressure. It was reported that patient ears rang all the time and had not let up yet at the time of reporting. It made it hard to go to sleep and the ringing was 24 hours a day. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the ringing in ears with pressure and hard to go to sleep was not recovered.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Contusion, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: Swelling at injection site.; Redness at injection site.; Itchy rash at injection site; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6199) via an unspecified route of administration in right arm on 08March2021 at 09:45 (at the age of 68-year-old), as a single dose for COVID-19 immunisation. Medical history included mild chronic obstructive pulmonary disease, high cholesterol and blood pressure. The patient was allergic to several pain medications, antibiotics and bee stings. The patient received unspecified medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccine within four weeks prior to COVID-19 vaccine. On 18March2021 at 12:30, after 10 days of vaccination the patient experienced injection site swelling, injection site redness and itchy rash at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events vaccination site swelling, vaccination site erythema and itchy rash. The clinical outcome of vaccination site swelling, vaccination site erythema and itchy rash was recovering at the time of this report.   No follow up attempts are needed. No further information is expected.